GLOBUS MEDICAL INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $104.3m $107.3m $156.5m $155.2m $102.3m $149.2m $190.2m $122.9m $103.0m $537.9m
Net Income (Loss) Available to Common Stockholders, Basic $104.3m $107.3m $156.5m $155.2m $102.3m $149.2m $190.2m $122.9m $103.0m $537.9m
Depreciation, Depletion and Amortization $38.8m $42.1m $41.6m $52.7m $62.9m $69.9m $68.3m $144.7m $254.0m $276.8m
Depreciation $35.3m $34.2m $32.0m $38.9m $46.0m $51.3m $50.5m $93.7m $134.7m $159.3m
Amortization of Intangible Assets $3.5m $7.9m $9.6m $13.8m $16.8m $18.5m $17.7m $51.0m $119.4m $118.2m
Deferred Income Tax Expense (Benefit) ($4.1m) $8.2m $971k $4.3m ($3.9m) ($17.6m) ($22.3m) ($58.2m) ($134.0m)
Share-based Payment Arrangement, Noncash Expense $11.4m $14.7m $21.9m $26.1m $27.1m $30.6m $32.8m $52.7m $54.2m $49.8m
Payment, Tax Withholding, Share-based Payment Arrangement $10.6m $6.7m $2.9m
Share-based Payment Arrangement, Expense $11.4m $14.7m $21.9m $26.1m $27.1m $30.6m $32.8m $39.0m $54.2m $49.8m
Goodwill and Intangible Asset Impairment $0
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0
Impairment of Intangible Assets, Finite-lived $0 $0 $0 $0 $0 $0
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $3.5m $516k $0 $0 $0 $0 $0 $0 $0
Share-based Payment Arrangement, Expensed and Capitalized, Amount $11.7m $14.9m $22.2m $26.4m $27.3m $31.3m $33.5m $52.8m $54.3m $76.5m
Gain (Loss) on Disposition of Assets $3.6m ($866k) ($809k) ($464k) ($299k) ($1.5m) ($5.6m) ($12.5m)
Income Tax Expense (Benefit) $52.9m $62.6m $32.1m $34.7m $23.6m $31.2m $52.9m $42.5m $17.7m $67.2m
Operating Lease, Expense $3.2m $3.6m $3.4m
Other Nonoperating Income (Expense) $3.1m $8.1m $19.3m $18.0m $14.5m $8.5m $15.1m $32.3m $2.2m $3.4m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $4.7m $25.0m $21.8m $18.3m ($10.7m) $25.9m $50.8m $49.9m $78.1m $52.2m
Increase (Decrease) in Inventories $10.5m $5.3m $31.4m $50.0m $50.1m $12.0m $61.7m $70.3m $29.9m $17.6m
Increase (Decrease) in Accounts Payable ($23k) $9.8m ($3.0m) $773k ($6.4m) $3.7m $14.4m ($14.2m) $17.7m $8.5m
Proceeds from Stock Options Exercised $5.9m $11.7m $39.3m $31.0m $72.3m $63.5m $41.7m $12.4m $110.4m $89.8m
Foreign Currency Transaction Gain (Loss), before Tax ($482k) $909k $360k $75k ($279k) ($1.4m) ($1.0m) $14.3m ($43.3m) ($3.0m)
Goodwill $105.9m $123.9m $123.7m $128.8m $156.7m $179.7m $197.5m $1.4b $1.4b $1.4b
Inventory Write-down $12.8m $11.5m $10.5m $2.5m $17.7m $6.1m $6.4m $11.0m $23.4m $22.1m
Nonoperating Income (Expense) ($45.3m) $125.3m
Operating Expenses $275.1m $323.7m $384.2m $433.4m $460.1m $546.9m $531.2m $887.2m
Restructuring Costs $23.8m $15.0m
Gain (Loss) on Derivative Instruments, Net, Pretax $14.1m ($43.3m) ($3.0m)
Net Cash Provided by (Used in) Operating Activities $171.9m $159.5m $181.6m $172.0m $198.8m $276.3m $178.5m $243.5m $520.6m $753.4m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $40.9m $51.3m $59.7m $70.8m $63.7m $56.9m $74.0m $78.3m $115.4m $164.7m
Payments to Acquire Businesses, Net of Cash Acquired $76.1m $29.9m $14.8m $23.8m $33.5m $34.5m $31.4m $296.0m $17.6m $252.5m
Payments to Acquire Investments $287.3m $392.9m $537.9m $346.5m $223.5m $622.4m $419.5m $100.6m $113.5m
Net Cash Provided by (Used in) Investing Activities ($99.6m) ($111.3m) ($193.0m) ($140.3m) ($117.3m) ($375.9m) ($110.4m) $303.0m ($176.1m) ($355.0m)
Cash flows from financing activities:
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $281.9m $240.4m $278.0m $247.0m $134.5m $227.9m $312.2m $240.2m $58.7m $63.9m
Payments for Repurchase of Common Stock $104.7m $144.5m $225.6m $85.8m $300.5m
Net Cash Provided by (Used in) Financing Activities $2.0m $1.6m $32.6m $24.4m ($38.7m) $54.1m ($110.0m) ($231.8m) ($27.7m) ($679.2m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($256k) ($156k) $865k ($810k) ($747k) $2.2m $255k $22.4m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $20.9m ($156k) $43.7m ($46.3m) ($42.6m) $316.8m $317.1m ($258.3m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $139.7m $195.7m $239.4m $193.1m $150.5m $467.3m $784.4m $526.2m
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net $50.1m $59.1m $30.6m $34.1m $25.4m $45.0m $77.8m $100.6m $158.5m $98.9m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.